Paskem Fine Chem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.00%
- Profit Growth 14.85%
- Ebitda -12.88%
- Net Worth 23.96%
- Total Assets 55.64%
About Paskem Fine Chem
Paskem Fine Chem Private Limited (PFCPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2018 (Six years and 11 months 27 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Kumar and Mukesh Kumar serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290UP2018PTC100925
-
Company No.
100925
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Paskem Fine Chem Private Limited offer?
Paskem Fine Chem Private Limited offers a wide range of products and services, including Analyzers & Analytical Instruments, PH Meter, Background Verification, Reference Verification Services.
Who are the key members and board of directors at Paskem Fine Chem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Kumar
|
Director | 12-Feb-2018 | Current |
|
Mukesh Kumar
|
Director | 12-Feb-2018 | Current |
Financial Performance of Paskem Fine Chem.
Paskem Fine Chem Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1% increase. The company also saw a substantial improvement in profitability, with a 14.85% increase in profit. The company's net worth Soared by an impressive increase of 23.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paskem Fine Chem?
In 2021, Paskem Fine Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Korana Biotech Private LimitedVikas Kumar and Mukesh Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Paskem Fine Chem?
Unlock and access historical data on people associated with Paskem Fine Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paskem Fine Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paskem Fine Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.